Parathyroidectomy for adults with primary hyperparathyroidism
Referencias
Additional references
Aberg V, Norenstedt S, Zedenius J, Sääf M, Nordenström J, Pernow Y, et al. Health‐related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double‐blind randomized study. European Journal of Endocrinology 2015;172(2):181‐7.
Alesina PF, Hinrichs J, Heuer M, Hofmeister S, Meier B, Walz MK. Feasibility of video‐assisted bilateral neck exploration for patients with primary hyperparathyroidism and failed or discordant localization studies. Langenbeck's Archives of Surgery 2013;398(1):107‐11.
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326(7382):219. [PUBMED: 12543843]
Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 2007;92(8):3114‐21.
Barczynski M, Konturek A, Hubalewska‐Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbeck's Archives of Surgery 2009;394(5):843‐9.
Bell ML, McKenzie JE. Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures. Psychooncology 2013;22(8):1738‐47.
Beller EM, Chen JK, Wang UL, Glasziou PP. Are systematic reviews up‐to‐date at the time of publication?. Systematic Reviews 2013;2:36. [2046‐4053: (Electronic)]
Best CAE, Krishnan R, Malvankar‐Mehta MS, MacNeil SD. Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta‐analysis. Medicine 2017;96(43):e7255.
Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet 2018;391(10116):168‐78. [PUBMED: 28923463]
Borenstein M, Higgins JP, Hedges LV, Rothstein HR. Basics of meta‐analysis: I² is not an absolute measure of heterogeneity. Research Synthesis Methods 2017;8(1):5‐18.
Borenstein M. Prediction intervals. www.meta‐analysis.com/prediction (accessed 3 July 2017).
Boutron I, Altman DG, Hopewell S, Vera‐Badillo F, Tannock I, Ravaud P. Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. Journal of Clinical Oncology 2014;32(36):4120‐6.
Brunaud L, Li Z, Van Den Heede K, Cuny T, Van Slycke S. Endoscopic and robotic parathyroidectomy in patients with primary hyperparathyroidism. Gland Surgery 2016;5(3):352‐60.
Buch MH, Aletaha D, Emery P, Smolen JS. Reporting of long‐term extension studies: lack of consistency calls for consensus. Annals of the Rheumatic Diseases 2011;70(6):886‐90.
CENTRAL creation details. www.cochranelibrary.com/help/central‐creation‐details.html (accessed 15 March 2018).
Cheng SP, Lee JJ, Liu TP, Yang PS, Liu SC, Hsu YC, et al. Quality of life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta‐analysis of randomized controlled trials. Medicine 2015;94(23):e931.
Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D, et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. Journal of Clinical Endocrinology and Metabolism 2015;100(4):1309‐15.
The CONSORT statement. www.consort‐statement.org (accessed 19 May 2016).
Corbett MS, Higgins JP, Woolacott NF. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Research Synthesis Methods 2014;5(1):79‐85.
Deeks JJ, Higgins JPT, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook.
Dobrinja C, Santandrea G, Giacca M, Stenner E, Ruscio M, de Manzini N. Effectiveness of intraoperative parathyroid monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease. International Journal of Surgery (London, England) 2017;41(Suppl 1):S26‐33.
Fyrsten E, Norlén O, Hessman O, Stålberg P, Hellman P. Long‐term surveillance of treated hyperparathyroidism for multiple endocrine neoplasia type 1: recurrence or hypoparathyroidism?. World Journal of Surgery 2016;40(3):615‐21.
Gagner M. Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism. British Journal of Surgery 1996;83(6):875.
Garas G, Holsinger FC, Grant DG, Athanasiou T, Arora A, Tolley N. Is robotic parathyroidectomy a feasible and safe alternative to targeted open parathyroidectomy for the treatment of primary hyperparathyroidism?. International Journal of Surgery (London, England) 2015;15:55‐60.
GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 19 April 2018. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K. Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one‐year prospective controlled study using high‐resolution peripheral quantitative computed tomography. Journal of Bone and Mineral Research 2012;27(5):1150‐8.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327(7414):557‐60.
Higgins JPT, Thompson SG, Spiegelhalter DJ. A re‐evaluation of random‐effects meta‐analysis. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009;172(1):137‐59.
Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687.
Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ 2017;358:j2998.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13]
Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):E201‐11.
Jones CW, Keil LG, Holland WC, Caughey MC, Platts‐Mills TF. Comparison of registered and published outcomes in randomized controlled trials: a systematic review. BMC Medicine 2015;13:282. [DOI: 10.1186/s12916‐015‐0520‐3]
Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis International 2017;28(1):1‐19. [PUBMED: 27613721]
Khosla S, Melton LJ, Wermers RA, Crowson CS, O'Fallon W, Riggs B. Primary hyperparathyroidism and the risk of fracture: a population‐based study. Journal of Bone and Mineral Research 1999;14(10):1700‐7.
Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: 10.1136/bmj.c365]
Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2013;98(8):3213‐20.
Kreidieh OI, Ahmadieh H, Akl EA, El‐Hajj FG. Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD010787]
Kuzminski SJ, Sosa JA, Hoang JK. Update in parathyroid imaging. Magnetic Resonance Imaging Clinics of North America 2018;26(1):151‐66.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLOS Medicine 2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100]
Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2015;100(4):1359‐67.
Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977‐84.
McMahon DJ, Carrelli A, Palmeri N, Zhang C, DiTullio M, Silverberg SJ, et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta‐analysis. Journal of Clinical Endocrinology and Metabolism 2015;100(12):4399‐407.
Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3:82.
Megan B, Pickering RM, Weatherall M. Design, objectives, execution and reporting of published open‐label extension studies. Journal of Evaluation in Clinical Practice 2012;18(2):209‐15.
Miccoli P, Pinchera A, Cecchini G, Conte M, Bendinelli C, Vignali E, et al. Minimally invasive, video‐assisted parathyroid surgery for primary hyperparathyroidism. Journal of Endocrinological Investigation 1997;20(7):429‐30.
Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, et al. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Annals of Surgery 2010;251(5):832‐7. [PUBMED: 20395857]
Nilsson IL, Norenstedt S, Zedenius J, Pernow Y, Bränström R. Primary hyperparathyroidism, hypercalciuria, and bone recovery after parathyroidectomy. Surgery 2017;162(2):429‐36.
Ning L, Sippel R, Schaefer S, Chen H. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?. Annals of Surgery 2009;249(3):469‐72.
Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. Journal of Surgical Research 2014;190(1):185‐90.
Pepe J, Cipriani C, Sonato C, Raimo O, Biamonte F, Minisola S. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. European Journal of Endocrinology 2017;177(6):R297‐308.
Ramakant P, Paul MJ, Paul TV, Rao SD, Abraham DT, Uttley L, et al. Surgery versus surveillance for asymptomatic (mild) primary hyperparathyroidism in adults 50 years or older. Cochrane Database of Systematic Reviews 2017, Issue 7. [DOI: 10.1002/14651858.CD010093.pub2]
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta‐analyses. BMJ 2011;342:d549.
Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.MR000005.pub3]
Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Akl E, et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook.
Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. Journal of Clinical Endocrinology and Metabolism 2014;99(10):3580‐94.
Singh Ospina N, Maraka S, Rodriguez‐Gutierrez R, Espinosa de Ycaza AE, Jasim S, Gionfriddo M, et al. Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta‐analysis. Osteoporosis International 2016;27(12):3395‐407.
Singh Ospina NM, Rodriguez‐Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda‐Guarderas A, et al. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta‐analysis. World Journal of Surgery 2016;40(10):2359‐77.
Smith ME, Pfleiderer AG, Shamil E. Open minimally invasive versus video‐assisted minimally invasive parathyroidectomy for primary hyperparathyroidism. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD012512]
Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002.
Sterne JAC, Egger M, Moher D, Boutron I (editors). Chapter 10: Addressing reporting biases. In: Higgins JPTG, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook.
Taieb A, Seman M, Menegaux F, Tresallet C. Surgical technique parathyroidectomy through a minimally invasive gland‐centred localized approach for primary hyperparathyroidism. Journal of Visceral Surgery 2013;150(6):403‐6.
Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G. Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2015;100(8):3069‐73.
Trombetti A, Christ ER, Henzen C, Gold G, Brändle M, Herrmann FR, et al. Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss primary hyperparathyroidism cohort: a focus on neuro‐behavioral and cognitive symptoms. Journal of Endocrinological Investigation 2016;39(5):567‐76.
Verdelli C, Corbetta S. Mechanisms in endocrinology: kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects. European Journal of Endocrinology 2017;176(1):R39‐52.
Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert‐Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (Clinical research ed) 2000;321(7261):598‐602.
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surgery 2016;151(10):959‐68.
Witteveen JE, van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the post‐operative management of primary hyperparathyroidism: a systematic review of the literature. European Journal of Endocrinology 2013;168(3):R45‐53.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5.
Yener Ozturk F, Erol S, Canat MM, Karatas S, Kuzu I, Dogan Cakir S, et al. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients. Endocrine Journal 2016;63(2):111‐8.
